samedan logo

home > pmps

Pharmaceutical Manufacturing and Packing Sourcer


Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new trends and marketing opportunities, as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market 

For further information please contact:

Simon Caplan

Will Brown

We're also on Twitter! Follow us @PMPSmag   


Click here to view the digital version of PMPS




Click here to view the digital version



Featured in this issue
Sustainability in Pharma
Sustainability in Pharma

Sustainability: Mapping Out the Lifecycle of Single-Use Medical Devices

Plastic waste is no longer something that companies can ignore, and the pharmaceutical industry is no different. Medical devices that can proactively adjust to the changing tide of single-use plastics are ready to support the ongoing global emergency of plastic pollution.
Temperature Control and Tracking
Temperature Control and Tracking

Building One True Control Tower

Single-use loggers are set to accumulate into their millions in the next few years. Multi-use options exist, but tend to be shunned in the face of demand. How can better support and real-time tracking help shift the sustainability tide in pharma?
  Inhalation Technology Supplement
Inhalation Technology Supplement

Pharmaceutical Dosage Forms

The production of the perfect dosage for dry powder inhalers is a challenge facing the industry, both for those inventing new products and those working with tried and tested methods. F rom particle shape to their size and the electrostatic charges, everything must be considered.


Published quarterly in
February, May,
August, and November


News and Press Releases

WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

PHILADELPHIA and OXFORD, March 2, 2021 - WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the acquisition of OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cutting-edge cell and gene therapies for patients in need worldwide.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement